Within the family program agenda, Aardvark's Chief Medical Officer, Manasi Jaiman, M.D., will join a panel of clinicians to discuss the details of the company's ongoing Phase 3 HERO study. Additional members of the company's medical and advocacy team invite the medical community and families attending to engage with attending team members at the company's booth to learn more about ARD-101, the HERO study and the company's commitment to the PWS community. SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Aardvark ...